trial · primary record
CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
Acute Myeloid Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Safety of infusion |
| Registry ID | NCT05995041 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:56.124Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05995041
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.